FDA Approvals

The DOGE-fueled firing of AI experts at the FDA endangers lives and worsens the hospital crisis
Commentary

The DOGE-fueled firing of AI experts at the FDA endangers lives and worsens the hospital crisis

By
February 27, 2025
Robert F. Kennedy Jr.
Health

With RFK Jr. in charge, supplement makers see chance to cash in

By KFF Health News and Arthur Allen
February 25, 2025
A woman takes pills at her desk
Health

The dietary supplements you think are improving your health may be damaging your liver, research warns

By
February 19, 2025
A woman holds a medicine bottle while reading instructions.
Health

Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive

By
February 15, 2025
A woman injects herself with medication.
Health

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

By
February 11, 2025
A young woman undergoes a brain scan.
Aging Well

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith
January 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By
January 29, 2025
Eli Lilly & Co., the Coins2Day 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
Aging Well

RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine

By
October 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
Health

COVID sickens older adults most severely, but less than half say they’ll get the new vaccine

By
September 30, 2024
Medical AI could be great. But the way we are regulating it now is dangerous
Newsletters

Medical AI could be great. But the way we are regulating it now is dangerous

By
September 17, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
Health

New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge

By
August 29, 2024
New COVID vaccine in its box
Health

FDA approves updated COVID-19 vaccines, shots should be available in days

By The Associated Press and Lauran Neergaard
August 22, 2024

Most Popular